NCT04081792View on ClinicalTrials.gov

Optimal Antibiotics for Operated Diabetic Foot Infections

NACompletedINTERVENTIONAL
Enrollment

643

Participants

Timeline

Start Date

September 4, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

March 1, 2025

Conditions
Diabetic Foot InfectionSurgical WoundAntibiotic Side EffectInfection
Interventions
PROCEDURE

Antibiotic therapy

Postoperative randomizations regarding the duration of systemic antibiotics

Trial Locations (1)

8008

Balgrist University Hospital, Zurich

All Listed Sponsors
lead

Balgrist University Hospital

OTHER

NCT04081792 - Optimal Antibiotics for Operated Diabetic Foot Infections | Biotech Hunter | Biotech Hunter